NCT07011095View on ClinicalTrials.gov

DOAC or VKA in Patients With AF and Stroke While on DOAC - a Pilot Trial

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 3, 2025

Primary Completion Date

February 3, 2027

Study Completion Date

June 3, 2027

Conditions
Atrial Fibrillation (AF)Stroke (in Patients With Atrial Fibrillation)
Interventions
DRUG

VKA

Warfarin

DRUG

Direct Oral Anticoagulant (DOAC)

Locally approved DOACs

Sponsors
All Listed Sponsors
lead

Population Health Research Institute

OTHER